NCT04067934

Brief Summary

Children and adolescents with inflammatory bowel disease are at increased risk of poor bone and muscle health through a variety of factors, including underlying disease processes, nutritional deficits, and reduced physical activity. Inflammatory bowel disease can also delay the onset of puberty in children, and pubertal development in adolescents, resulting in sub-optimal adult bone mass, therefore increasing future risk of fractures and osteoporosis. High impact exercise may be a useful additional therapy for adolescents with IBD, as the mechanical strains produced during this type of exercise, through high force muscular contractions and ground reaction forces, can promote bone formation and gains in muscle mass. There have been no previous studies assessing the effects of high impact exercise in IBD, so it is unknown if this type of exercise is feasible in this population. The aim of this study is to assess the feasibility of a short term jumping based exercise intervention for improving muscle and bone outcomes in children and adolescents with inflammatory bowel disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

1.9 years

First QC Date

July 25, 2019

Last Update Submit

August 23, 2019

Conditions

Keywords

PaediatricsExercise

Outcome Measures

Primary Outcomes (1)

  • Adherence to exercise protocol

    Number of exercise repetitions/sessions completed

    4 weeks

Secondary Outcomes (8)

  • Bone metabolism biomarker

    Baseline and 4 weeks

  • Growth hormone axis

    Baseline and 4 weeks

  • Inflammatory cytokines

    Baseline and 4 weeks

  • Muscle function

    Baseline and 4 weeks

  • Disease activity

    Baseline and 4 weeks

  • +3 more secondary outcomes

Study Arms (1)

Jumping exercise

EXPERIMENTAL

High-impact exercise intervention: 3 sessions per week for four weeks Each session will consist of three jumping-based exercises, performed for three sets of various repetitions, following a progressive protocol with increasing volume/intensity.

Behavioral: Jumping Exercise programme

Interventions

Four weeks of three jumping-based exercise sessions per week. These sessions will involve basic jumping movements, with approximately 50-100 jumps per session; incorporating 20-30 minutes of exercise.

Jumping exercise

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • confirmed diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis) at least 6 months prior to study involvement
  • aged 10 to 17.9 years (inclusive)
  • ability to provide written informed consent, or assent with accompanying parent/guardian consent
  • ability to mobilise and perform exercise independently
  • disease in remission, or mildly/moderately active, according to weighted Paediatric Crohn's disease activity index (wPCDAI) or Paediatric ulcerative colitis activity index (PUCAI)
  • stable medication for \>4 weeks prior to study, and no planned changes of medication during study period

You may not qualify if:

  • lack of capacity to provide consent or assent
  • pregnancy (females)
  • recent (\<12 weeks) surgery, or planned surgery during intervention period
  • significant contraindication to high-impact exercise
  • significant comorbidity
  • use of medication known to affect bone turnover (excluding that used to treat IBD \[i.e. glucocorticoids\])
  • BMI \> +3.5 standard deviation score (SDS)
  • participating in \>2 hours per week structured exercise (excluding school physical education)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NHS Greater Glasgow and Clyde

Glasgow, United Kingdom

Location

MeSH Terms

Conditions

Inflammatory Bowel DiseasesMotor Activity

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesBehavior

Study Officials

  • Jarod Sze Choong Wong, MBBS MRCPCH DMedSc

    University of Glasgow

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lewis Steell, BSc MSc

CONTACT

Jarod Sze Choong Wong, MBBS MRCPCH DMedSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pilot/feasibility design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2019

First Posted

August 28, 2019

Study Start

August 1, 2019

Primary Completion

July 1, 2021

Study Completion

July 1, 2021

Last Updated

August 28, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations